Pyrimethamine Market Size, CAGR, Trends 2022–2030
Pyrimethamine is a folic acid antagonist that inhibits the dihydrofolate reductase enzyme, disrupting the reproduction of parasites such as Plasmodium (responsible for malaria) and Toxoplasma gondii. While its primary indication is for malaria, it is often prescribed alongside sulfadiazine